Cargando…
Toxins Targeting the K(V)1.3 Channel: Potential Immunomodulators for Autoimmune Diseases
Autoimmune diseases are usually accompanied by tissue injury caused by autoantigen-specific T-cells. K(V)1.3 channels participate in modulating calcium signaling to induce T-cell proliferation, immune activation and cytokine production. Effector memory T (T(EM))-cells, which play major roles in many...
Autores principales: | Zhao, Yipeng, Huang, Jie, Yuan, Xiaolu, Peng, Biwen, Liu, Wanhong, Han, Song, He, Xiaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448172/ https://www.ncbi.nlm.nih.gov/pubmed/25996605 http://dx.doi.org/10.3390/toxins7051749 |
Ejemplares similares
-
Kv1.3 channel blocker (ImKTx88) maintains blood–brain barrier in experimental autoimmune encephalomyelitis
por: Huang, Jie, et al.
Publicado: (2017) -
Blockade of Kv1.3 Potassium Channel Inhibits Microglia-Mediated Neuroinflammation in Epilepsy
por: Zhang, Xinyi, et al.
Publicado: (2022) -
The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases
por: Ye, Fang, et al.
Publicado: (2016) -
Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype
por: Hou, Baohua, et al.
Publicado: (2020) -
Immunomodulation by memantine in therapy of Alzheimer's disease is mediated through inhibition of K(v)1.3 channels and T cell responsiveness
por: Lowinus, Theresa, et al.
Publicado: (2016)